SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-24-039843
Filing Date
2024-09-03
Accepted
2024-09-03 07:21:19
Documents
59
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 6-K ef20031114_6k.htm   iXBRL 6-K 43739
2 EXHIBIT 99.1 ef20031114_ex99-1.htm   iXBRL EX-99.1 625901
3 EXHIBIT 99.2 ef20031114_ex99-2.htm EX-99.2 197834
4 EXHIBIT 99.3 ef20031114_ex99-3.htm EX-99.3 155751
10 image00008.jpg GRAPHIC 12028
11 image00010.jpg GRAPHIC 2807
  Complete submission text file 0001140361-24-039843.txt   3690129

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ghrs-20240630.xsd EX-101.SCH 39114
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ghrs-20240630_cal.xml EX-101.CAL 49838
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ghrs-20240630_def.xml EX-101.DEF 58986
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ghrs-20240630_lab.xml EX-101.LAB 377295
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ghrs-20240630_pre.xml EX-101.PRE 195758
62 EXTRACTED XBRL INSTANCE DOCUMENT ef20031114_6k_htm.xml XML 492564
Mailing Address JOSHUA DAWSON HOUSE DAWSON STREET DUBLIN 2 L2 D02 RY95
Business Address JOSHUA DAWSON HOUSE DAWSON STREET DUBLIN 2 L2 D02 RY95 353 1 437 8334
GH Research PLC (Filer) CIK: 0001855129 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40530 | Film No.: 241271901
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)